Synthesis and Biopharmaceutical Characterization of Amphiphilic Squalenyl Derivative Based Versatile Drug Delivery Platform.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
de Rossi, Chiara
Schaefer, Ulrich F
MetadataShow full item record
AbstractHepatitis C virus (HCV) has no animal reservoir, infecting only humans. To investigate species barrier determinants limiting infection of rodents, murine liver complementary DNA library screening was performed, identifying transmembrane proteins Cd302 and Cr1l as potent restrictors of HCV propagation. Combined ectopic expression in human hepatoma cells impeded HCV uptake and cooperatively mediated transcriptional dysregulation of a noncanonical program of immunity genes. Murine hepatocyte expression of both factors was constitutive and not interferon inducible, while differences in liver expression and the ability to restrict HCV were observed between the murine orthologs and their human counterparts. Genetic ablation of endogenous Cd302 expression in human HCV entry factor transgenic mice increased hepatocyte permissiveness for an adapted HCV strain and dysregulated expression of metabolic process and host defense genes. These findings highlight human-mouse differences in liver-intrinsic antiviral immunity and facilitate the development of next-generation murine models for preclinical testing of HCV vaccine candidates.
CitationFront Chem. 2020 Oct 19;8:584242. doi: 10.3389/fchem.2020.584242.
AffiliationHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
JournalFrontiers in chemistry
The following license files are associated with this item:
- Creative Commons
- Self-Assembled Amphiphilic Starch Based Drug Delivery Platform: Synthesis, Preparation, and Interactions with Biological Barriers.
- Authors: Phan VHG, Trang Duong HT, Tran PT, Thambi T, Ho DK, Murgia X
- Issue date: 2021 Feb 8
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases.
- Authors: Christmann R, Ho DK, Wilzopolski J, Lee S, Koch M, Loretz B, Vogt T, Bäumer W, Schaefer UF, Lehr CM
- Issue date: 2020 Nov 24
- Novel self assembling nanoparticles for the oral administration of fondaparinux: synthesis, characterization and in vivo evaluation.
- Authors: Ralay-Ranaivo B, Desmaële D, Bianchini EP, Lepeltier E, Bourgaux C, Borgel D, Pouget T, Tranchant JF, Couvreur P, Gref R
- Issue date: 2014 Nov 28
- A Scalable Method for Squalenoylation and Assembly of Multifunctional <sup>64</sup>Cu-Labeled Squalenoylated Gemcitabine Nanoparticles.
- Authors: Tucci ST, Seo JW, Kakwere H, Kheirolomoom A, Ingham ES, Mahakian LM, Tam S, Tumbale S, Baikoghli M, Cheng RH, Ferrara KW
- Issue date: 2018
- Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation.
- Authors: Dosio F, Reddy LH, Ferrero A, Stella B, Cattel L, Couvreur P
- Issue date: 2010 Jul 21